Contact Levi & Korsinsky by August 29, 2025 Deadline to Join Class Action Against Petco Health and Wellness Company, Inc. (WOOF)

(NASDAQ:WOOF), NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Petco Health and Wellness Company, Inc. (“Petco” or the “Company”) (NASDAQ: WOOF) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Petco investors who were adversely affected by alleged securities fraud […]

Investors who lost money on Alto Neuroscience, Inc. (ANRO) should contact Levi & Korsinsky about pending Class Action – ANRO

Investors who lost money on Alto Neuroscience, Inc. (ANRO) should contact Levi & Korsinsky about pending Class Action – ANRO GlobeNewswire August 14, 2025 NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Alto Neuroscience, Inc. (“Alto Neuroscience, Inc.” or the “Company”) (NYSE: ANRO) of a class action securities

Contact Levi & Korsinsky by August 29, 2025 Deadline to Join Class Action Against Petco Health and Wellness Company, Inc. (WOOF)

Contact Levi & Korsinsky by August 29, 2025 Deadline to Join Class Action Against Petco Health and Wellness Company, Inc. (WOOF) GlobeNewswire August 14, 2025 NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Petco Health and Wellness Company, Inc. (“Petco” or the “Company”) (NASDAQ: WOOF) of a class

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sarepta Therapeutics, Inc. (SRPT) Shareholders

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sarepta Therapeutics, Inc. (SRPT) Shareholders GlobeNewswire August 14, 2025 NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT) of a class action securities lawsuit. CLASS DEFINITION:

Freckie Capital Enters US Market to Redefine Intelligent Investing Through Strategic Thinking

Intelligent wealth management platform Freckie Capital today announced its official entry into the United States, marking a milestone in the company's global expansion strategy. At the heart of this launch is Freckie Capital's proprietary NAT System (Nova Alpha Terminal) – a next-generation investment engine that combines structured thinking, advanced analytics, and behavioral finance to deliver

Globant Reports 2025 Second Quarter Financial Results

Globant (NYSE: GLOB) today announced results for the three months ended June 30, 2025. https://mma.prnewswire.com/media/959011/Globant_logo_actualizado.jpg “This quarter, we continued making the strategic investments and bold moves needed to fully align with our new business model. As GenAI adoption accelerates across industries and the AI ecosystem grows in complexity, our market opportunity expands even further. Our

Social Casino Sign-Up Bonus 2025: Crown Coins Voted Leading Online Casino Bonus

WASHINGTON, DC, Aug. 14, 2025 (GLOBE NEWSWIRE) — Social Casino Sign-Up Bonus 2025: Crown Coins Voted Leading Online Casino Bonus CasinoTop10.net has recognised Crown Coins Casino's signature sign-up bonus as the top casino bonus in the sweepstakes category. As highlighted by casino experts, the Crown Coins bonus has set the gold standard following slight revisions

Reviva Reports Second Quarter 2025 Financial Results and Recent Business Highlights

(NASDAQ:RVPH), – Well-tolerated safety profile and robust broad-spectrum efficacy sustained over 1-year across all symptom domains including negative symptoms in open label extension (OLE) 1-year trial- – Successful completion of two large randomized double-blind clinical trials, including one Phase 2 and one Phase 3 trial, a 1-year OLE trial, and clinical pharmacology studies designed to

Reviva Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Reviva Reports Second Quarter 2025 Financial Results and Recent Business Highlights GlobeNewswire August 14, 2025 – Well-tolerated safety profile and robust broad-spectrum efficacy sustained over 1-year across all symptom domains including negative symptoms in open label extension (OLE) 1-year trial- – Successful completion of two large randomized double-blind clinical trials, including one Phase 2 and

Social Casino Sign-Up Bonus 2025: Crown Coins Voted Leading Online Casino Bonus

Social Casino Sign-Up Bonus 2025: Crown Coins Voted Leading Online Casino Bonus Award-Winning Sweepstakes Casino Bonus Offers New Players Extra Coins, Fair Terms, and Top-Rated Gameplay in 2025 GlobeNewswire August 14, 2025 WASHINGTON, DC, Aug. 14, 2025 (GLOBE NEWSWIRE) — Social Casino Sign-Up Bonus 2025: Crown Coins Voted Leading Online Casino Bonus CasinoTop10.net has recognised

Scroll to Top